drugset / Trial / NCT00654303

OLE Study to Evaluate Safety / Efficacy of ZD4522

NCT00654303

Phase 3 Completed 3500 enrolled AstraZeneca
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the long term safety of Crestor.

Timeline

Start
1999-08
Primary completion
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule

Indications